Institute of Pathology, University of Bern, Bern, Switzerland.
Allergy. 2012 Dec;67(12):1483-90. doi: 10.1111/all.12065. Epub 2012 Oct 29.
Over the last decades, considerable efforts have been undertaken in the development of animal models mimicking the pathogenesis of allergic diseases occurring in humans. The mouse has rapidly emerged as the animal model of choice, due to considerations of handling and costs and, importantly, due to the availability of a large and increasing arsenal of genetically modified mouse strains and molecular tools facilitating the analysis of complex disease models. Here, we review latest developments in allergy research that have arisen from in vivo experimentation in the mouse, with a focus on models of food allergy and allergic asthma, which constitute major health problems with increasing incidence in industrialized countries. We highlight recent novel findings and controversies in the field, most of which were obtained through the use of gene-deficient or germ-free mice, and discuss new potential therapeutic approaches that have emerged from animal studies and that aim at attenuating allergic reactions in human patients.
在过去的几十年中,人们在开发模拟人类过敏疾病发病机制的动物模型方面付出了巨大努力。由于考虑到处理和成本因素,尤其是由于大量不断增加的遗传修饰小鼠品系和分子工具的可用性,使得分析复杂疾病模型变得更加容易,因此小鼠迅速成为首选的动物模型。在这里,我们综述了源于小鼠体内实验的过敏研究的最新进展,重点介绍食物过敏和过敏性哮喘模型,这些模型是在工业化国家发病率不断增加的主要健康问题。我们强调了该领域的最新新发现和争议,其中大多数是通过使用基因缺失或无菌小鼠获得的,并讨论了一些新的潜在治疗方法,这些方法是从动物研究中得出的,旨在减轻人类患者的过敏反应。